AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · IEX Real-Time Price · USD
3.300
+0.080 (2.48%)
Mar 28, 2024, 9:49 AM EDT - Market open

AN2 Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Net Income
-42.78-28.06-14.58
Depreciation & Amortization
0.0800
Share-Based Compensation
4.390.970.04
Other Operating Activities
3.030.098.2
Operating Cash Flow
-33.46-20.48-5.36
Change in Investments
-21.77-50.020
Investing Cash Flow
-21.77-50.020
Share Issuance / Repurchase
70.360.010.06
Other Financing Activities
-78.523.77
Financing Cash Flow
70.3678.543.84
Net Cash Flow
15.128.03-1.53
Free Cash Flow
-33.46-20.48-5.36
Free Cash Flow Per Share
-2.18-7.76-2.09
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).